About
Treatments for Life-Limiting Diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
510
By Phase
PHASE2: 4
By Status
COMPLETED: 2RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07193563Lead Sponsor
A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
PHASE2Recruiting
220 participants
Started: Sep 5, 2025 · Completed: Mar 31, 2027
NCT06653296Lead Sponsor
A Dose-Response Safety Study of ENX-102 in Patients With GAD
PHASE2Completed
38 participants
Started: Dec 9, 2024 · Completed: Jun 23, 2025
NCT05749055Lead Sponsor
ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder
PHASE2Completed
252 participants
Started: Jul 3, 2023 · Completed: Sep 18, 2025
NCT05481905Lead Sponsor
ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures
PHASE2Withdrawn
Started: Sep 30, 2022 · Completed: Dec 31, 2024
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...